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Abstract: Species of the genus Tabebuia are used in traditional medicine and are reported in the literature for their properties against 
various diseases. The objective of this study was to evaluate the antipyretic, sedative and hypnotic activities of methanol extract of Tabebuia 
hypoleuca stems (THME) using the Brewer’s yeast induced pyrexia, Open field and Sodium thiopental-induced sleeping time tests, 
respectively. In the Brewer’s yeast induced pyrexia test, THME at 500 mg/kg produced a significant (p<0.001) decrease of the fever as from 
the first hour after administration and was sustained for 4 h. In the Open-field test, THME did not cause any significant change in the 
number of crossings, rearing, preening and defecation, and either in the time of immobility. Moreover, THME did not produce changes in 
neither the sleeping latency nor the sleeping time induced by sodium thiopental. These results showed that THME administered orally at 500 
mg/kg exerts antipyretic activity, probably mediated by the inhibition of the enzyme cyclooxygenase-2. This study also showed that THME 
does not exert sedative and hypnotic effects at the doses tested. 
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Resumen: Especies del género Tabebuia se utilizan en la medicina tradicional y se reportan en la literatura por sus propiedades contra 
diversas enfermedades. El objetivo de este estudio fue evaluar la actividad antipirética, sedante e hipnótica del extracto metanólico de los 
tallos de Tabebuia hypoleuca (THME) utilizando las pruebas de pirexia inducida por levadura de cerveza, campo abierto y tiempo de sueño 
inducido por tiopental sódico respectivamente. En el ensayo de pirexia inducida por levadura de cerveza, THME a 500 mg/kg produjo una 
reducción significativa (p<0.001) de la fiebre a partir de la primera hora después de la administración y se mantuvo durante cuatro horas. En 
el ensayo de campo abierto, THME no causó ningún cambio significativo en el número de cruces, levantamientos, acicalamientos y 
defecación, ni en el tiempo de inmovilidad. Además, THME no produjo cambios ni en la latencia de sueño, ni en el tiempo de sueño 
inducido por tiopental sódico. Estos resultados mostraron que THME administrado oralmente en dosis de 500 mg/kg posee actividad 
antipirética, mediado probablemente a la inhibición de la enzima ciclooxigenasa-2. Este estudio también demostró que THME no posee 
actividad sedante e hipnótica en las dosis ensayadas. 
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INTRODUCTION  
Pyrexia or fever is the increase in body temperature 
above normal physiological range (36.5 - 37.5 °C). 
It is a result of secondary impact of infection, tissue 
damage, inflammation, graft rejection, malignancy 
or other diseased states. The infected or damaged 
tissue initiates the increase formation of pro-
inflammatory mediators  such as cytokines, 
interleukin, interferon and tumor necrosis factor α 
(TNF-α) which increase the synthesis of 
prostaglandin E2 (PGE2) near the peptic 
hypothalamus area  and the prostaglandin in turn act 
on the hypothalamus to elevate the body 
temperature (Sultana et al., 2015). 
The elevated body temperature is reduced 
by non-steroidal anti-inflammatory drugs (NSAIDs) 
which inhibit cyclooxygenase (COX) expression 
thereby inhibiting prostaglandin synthesis. 
However, these synthetic antipyretic agents inhibit 
the COX-2 with high selectivity but they have toxic 
effects on other organs like glomeruli, cortex of the 
brain, hepatic cells and heart muscles (Vane & 
Botting, 1995; Bhowmick et al., 2014). This fact 
explains the need to search for new safer and more 
effective therapeutic options.  
Tabebuia spp. (Bignoniaceae) includes 
approximately 100 species, known as strictly 
woody, found in tropical rain forest areas 
throughout Central and South America (Olmstead et 
al., 2009). Species of the genus Tabebuia have been 
traditionally used and are reported in the literature 
for their properties to treat syphilis, malaria, 
cutaneous infections, stomach disorders, fever, 
cancer, inflammation, pain, bacterial and fungal 
infections, anxiety, poor memory, irritability, 
depression and others (De Miranda et al., 2001; 
Higa et al., 2011; Sadananda et al., 2011; Gómez et 
al., 2012, Lee et al., 2012; Franco et al., 2013; 
Freitas et al., 2013; Cragg et al., 2014; Ferreira et 
al., 2014).      
Tabebuia hypoleuca (C. Wright ex 
Sauvalle) Urb. commonly known as “Roble macho” 
is an species endemic of Cuba and native to Sierra 
Maestra and Guantanamo. Regalado et al. (2015) 
demonstrated the anti-inflammatory activity of the 
methanol extract of T. hypoleuca stems (THME) 
using the carrageenin-induced paw edema models 
and the croton oil induced auricular edema in mice. 
Subsequently, Regalado et al. (2017) demonstrated 
the antinociceptive activity of this extract using 
several models (chemical and thermal) of 
nociception in mice and suggested that the effect 
was mediated by the participation of both peripheral 
and central antinociceptive mechanisms.  
The present study was carried out to 
evaluate the antipyretic activity of THME 
administered orally in rats. Moreover, this study 
aimed to investigate sedative and hypnotic effect in 
order to exclude the possibility that the 
antinociceptive action shown in previous studies 
could be related to non-specific disturbances in the 
locomotor activity of the animals, affecting motor 
coordination as a consequence of sedation, 
hallucination, anxiety or fear. 
 
MATERIAL AND METHODS 
Plant material and extraction 
T. hypoleuca stems were collected at the National 
Botanical Garden (JBN), Havana province, Cuba. 
The identification of the plant was confirmed by Dr. 
R. Eldis Becquer and the sample was deposited in 
the herbarium of the experimental station with the 
number HFC-88204. The total extract was obtained 
from 330 g of T. hypoleuca stems by solid-liquid 
extraction in Soxhlet apparatus with methanol 
(Merck®). The methanol extract was filtered and 
concentrated by rotary evaporation. 
 
Drugs and chemicals 
The extract and all drugs were diluted in 0.9% 
saline solution (NaCl diluted in distilled water). The 
drugs and chemicals used were: paracetamol 
(SOLMED, Havana, Cuba), thiopental sodium 
(Quimefa, Havana, Cuba), diazepam (AICA, 
Havana, Cuba) and methanol (Merck, Germany). 
 
Animals 
Male Sprague-Dawley rats (180-200 g) and Male 
Balb/c mice (20-25 g) were supplied by the National 
Center for Laboratory Animal Production 
(CENPALAB, Santiago de Las Vegas, Havana, 
Cuba). Animals were raised under standard 
conditions of 23 ± 2 °C with 40-60% relative 
humidity under a 12/12 h light-dark cycle, and were 
given food and water ad libitum for seven days. All 
experimental procedures were performed in 
accordance with International Guidelines for the 
Care and Use of Laboratory Animals and approved 
by the Animal Ethical Committee of the National 
Center for Animal and Plant Health (CENSA), 
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Havana, Cuba. The number of animals and the 
intensity of the noxious stimuli were the minimum 
necessary to obtain reliable data. 
 
Antipyretic activity:  Brewer’s yeast induced 
pyrexia method 
The antipyretic activity of THME was evaluated 
using Brewer's yeast induced pyrexia in rats as 
described by Asongalem et al. (2004). Male rats 
were divided into ﬁve groups of six rats each. 
Hyperthermia was induced by subcutaneous 
injection of 25% Brewer's yeast (1 mL/100 g body 
weight). Before yeast injection, basal rectal 
temperature of rats was recorded. At the18h after 
yeast injection, the rectal temperatures were 
recorded again, and the animals were treated orally 
with paracetamol (150 mg/kg), distilled water (10 
ml/kg), and THME (150, 300 and 500 mg/kg). 
Rectal temperature was recorded by digital 
thermometer at 0th, 1st, 2nd, 3rd and 4th h after drug 
administration. The percent reduction in pyrexia 
was calculated by the following formula: 
 
 
 
 
 
 
 
 
 
Sedative activity: Open-field test 
The apparatus consisted of a plastic box measuring 
45×45×20 cm, with the floor divided into nine equal 
squares 15×15 cm (Spindola et al., 2012). Each 
mouse was gently placed at the centre of the open 
field and the following parameters were registered 
for 6 min: crossing (the number of squares crossed 
with all paws), rearing (rising on hind paws), 
preening, defecation and time of immobility (De 
Mattos et al., 2007).  For this purpose, male mice 
were divided into ﬁve groups of six mice each. The 
animals were treated orally with diazepam (4 
mg/kg), distilled water (10 ml/kg), and THME (150, 
300 and 500 mg/kg) 60 min beforehand. The floor 
of the open field was cleaned with ethanol after 
each session.  
 
Hypnotic activity: Sodium thiopental-induced 
sleeping time test 
The experiment was conducted following the 
method described by Ferrini et al. (1974). Male 
mice were divided into ﬁve groups of six mice each. 
The animals were treated orally with diazepam (1 
mg/kg), distilled water (10 ml/kg), and THME (150, 
300 and 500 mg/kg). Sixty minutes later, thiopental 
sodium (40 mg/kg, i.p) were administered to each 
mouse to induce sleep. The animals were observed 
and the following parameters were registered: 
sleeping latency (time between thiopental 
administrations to loss of righting reflex) and 
sleeping time (time between the loss and recovery 
of righting reflex). 
 
Statistical analysis 
Statistical analysis was performed using the 
statistical software package SPSS (version 21.0). 
The data were expressed as mean ± SEM. One-way 
ANOVA, followed by Dunnett's post hoc test was 
applied to determine the significant differences 
between the control and treated groups. P-values < 
0.05 were considered statistically significant. 
 
RESULTS  
Antipyretic activity 
In this test the animals showed a marked increase of 
rectal temperature after 18 h of subcutaneous 
injection of Brewer's yeast. Subsequently, the oral 
administration of THME at 500 mg/kg and 
paracetamol at 150 mg/kg, caused a significant 
reduced (p < 0.001) yeast induced pyrexia in rats as 
from the first hour after administration and was 
sustained for 4 h, while control group and THME at 
150 and 300 mg/kg showed no antipyretic activity 
in the entire period of experiment (Table 1). The 
maximum antipyretic effect of THME and 
paracetamol was observed at 2 h, with a maximum 
inhibition percentage of 54.76% and 72.59% 
respectively
.  
                     Pyrexia induction temperature – Post-treatment temperature 
Percent reduction = --------------------------------------------------------------------------   x 100 
                      Pyrexia induction temperature – Normal body temperature 
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Table 1 
Effect of the oral administration of THME (150, 300, 500 mg/kg) and paracetamol (150 mg/kg) on 
Brewer's yeast induced pyrexia test in rats. 
Treatment Dose 
Temperature in oC 
Initial             18 h                 1 h                    2 h                  3 h                 4 h 
Control 10ml/kg 37.22 ± 0.07 39.73 ± 0.08 39.68 ± 0.08 39.52 ± 0.21 39.75 ± 0.11  39.70 ± 0.08 
Paracetamol 150mg/kg 37.23 ± 0.10 39.55 ± 0.09 
38.02 ± 0.21***  
(68.5%) 
37.90 ± 0.12***  
(72.6%) 
37.95 ± 0.18***  
(71.8%) 
38.00 ± 0.09***  
(67.7%) 
THME 150mg/kg 37.12 ± 0.17 39.78 ± 0.08 
39.42 ± 0.11  
(13.3%) 
39.28 ± 0.29  
(20.6%) 
39.53 ± 0.11  
(8.8%) 
39.72 ± 0.08  
(2.5%) 
THME 300mg/kg 37.22 ± 0.12 39.68 ± 0.10 
39.35 ± 0.15  
(13.5%) 
39.10 ± 0.13  
(22.4%) 
39.47 ± 0.17  
(8.6%) 
39.37 ± 0.21  
(13.8%) 
THME 500mg/kg 37.17 ± 0.08 39.43 ± 0.11 
38.58 ± 0.23***  
(37.3%) 
38.22 ± 0.11***  
(54.8%) 
38.37 ± 0.09***  
(47.6%) 
38.30 ± 0.06***  
(50.5%) 
Values are expressed as mean ± SEM (n = 6). 
*** P < 0.001 vs. control group by one-way ANOVA followed by the Duncan´s Test. 
 
 
 
Regalado et al.                                                                                 Antipyretic, sedative and hypnotic evaluation of Tabebuia hypoleuca Titulo corto) 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/551 
 
Sedative activity 
The oral administration of THME (150, 300 and 500 
mg/kg) did not cause any significant change in the 
crossing (Figura 1A), rearing (Figura 1B), preening 
(Figura 1C), defecation (Fig. 1D) and time of 
immobility (Figura 1E) compared to the control  
 
group over a 5-min period. However, the group 
treated with diazepam (4 mg/kg, p.o.) showed a 
significantly diminution (p < 0.01, p < 0.001) of these 
parameters in comparison with the control group 
(Figuras 1A, B, C, D, E).  
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Figura 1. Effect of the oral administration of THME (150, 300, 500 mg/kg) and diazepam (4 mg/kg) in the open-field test. 
Crossing (A), rearing (B), preening (C), defecation (D) and time of immobility (E) were recorded. The results are 
presented as mean ± SEM (n=6). **p < 0.01, ***p < 0.001 vs. control group (one-way ANOVA followed by Dunnett test). 
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Hypnotic activity 
Treatment with THME (150, 300 and 500 mg/kg, 
p.o.) did not produce changes in neither the sleeping 
latency (Figura 2A) nor the sleeping time induced 
by sodium thiopental (Fig. 2B), while diazepam (1 
mg/kg, p.o.) signiﬁcantly reduced (p < 0.001) the 
sleeping latency (Figura 2A) and the sleeping time 
(Figura 2B) compared with control group.  
 
 
 
DISCUSSION 
The World Health Organization (WHO) estimates 
that 80% of population depends on herbal 
preparations for their health care. In recent years 
interest in the WHO has grown in traditional 
medicine and ways are being sought to add 
traditional medicines to the International 
Classification of Diseases (ICD). Traditional 
medicines could become an effective resource for 
linking the Western and Eastern hemispheres 
(Kawahara et al., 2010). 
The present study was designed to 
determine the antipyretic, sedative and hypnotic 
activities of THME. The dose levels used to assess 
these pharmacological effects were selected based 
on a previous report of anti-inflammatory and 
antinociceptive activities for this extract (Regalado 
et al., 2015; Regalado et al., 2017). 
To evaluate the antipyretic activity of 
THME, Brewer’s yeast induced pyrexia test in rat 
were used. It is considered as a valuable in vivo 
screening test for the assessment of antipyretic 
potential (Rauf et al., 2014). Brewer’s yeast induces 
release of pyrogens which are subsequently 
phagocytized by Kupffer cells, monocytes and 
macrophages. Enhanced release of pro-
inﬂammatory cytokines from these cells causes an 
increase in the synthesis of prostaglandins (Okokon 
et al., 2012). The increased production of PGE2 
stimulates the hypothalamus to generate responses 
to raise the body temperature (Shah & Seth, 2010). 
Although pyrexia causes unnecessary suffering and 
discomfort, it is considered as a natural defense 
mechanism that creates an environment where 
infectious agent or damaged tissue cannot survive 
(Mbiri et al., 2016).   
Studies have established that at least two 
COX isoenzyme exist, COX-1 and COX-2. The 
COX-1 is expressed constitutively and generally 
produces PGs to modulate physiological processes, 
synthesizes prostaglandins that protect the stomach 
and the kidney from damage; whereas COX-2 is 
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Fig. 2. Effect of the oral administration of THME (150, 300, 500 mg/kg) and diazepam (1 mg/kg) in the Sodium 
thiopental (45 mg/kg) induced sleeping time test. Sleeping latency (A) and sleeping times (B) were recorded. The results 
are presented as mean ± SEM (n=6). ***p < 0.001 vs. control group (one-way ANOVA followed by Dunnett test). 
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inducible and typically produces proinflammatory 
PGs in response to physiological stresses such as 
infection and inflammation; stimulates PGE2 
production that contributes to fever induction (Vane 
& Botting, 1998; Lee et al., 2007). 
NSAIDs such as aspirin, paracetamol, 
diclofenac and ibuprofen are the commonly used in 
the medication of fever (Warden, 2010). Most of the 
antipyretic drugs including the paracetamol 
(reference drug in this study) usually inhibit the 
cyclooxygenase (COX-2) expression and decreased 
the body temperature by reducing the synthesis of 
prostaglandins. Induction of toxicity to hepatic and 
renal glomerulus is evident with paracetamol during 
clinical treatment and in animal models (Jan & 
Khan, 2016). Continuous search for alternative 
therapeutic agents with minimum adverse effects is 
therefore necessary. 
In this test, the oral administration of 
THME at 500 mg/kg, caused a significant reduced 
of yeast induced pyrexia in rats as from the first 
hour after administration and was sustained for 4 h. 
The results of this study suggest that the antipyretic 
activity of THME in Brewer’s yeast induced 
pyrexia in rat could be attributed to the inhibition of 
the enzyme COX-2 responsible for the production 
of PGE2. 
In addition, THME at the same doses was 
studied for evaluated the central nervous system 
depressant effect using rodent behavioral models, 
such as Open field and Sodium thiopental-induced 
sleeping time tests in mice. 
Initially, the open field test was performed 
in order to exclude the possibility that the 
antinociceptive action of THME shown in previous 
studies could be related to non-specific disturbances 
in the locomotor activity of the animals (Prut & 
Belzung, 2003; Spindola et al., 2012). Treatment 
with THME (150, 300 and 500 mg/kg, p.o.) did not 
cause any significant change in the locomotor 
coordination activity of mice when tested in the 
open field. The results therefore, eliminate the 
possibility of locomotor impairment in the 
antinociceptive activity of the extract. In open-field 
tests when the animals are taken out from their 
home cage and placed in a new environment, they 
express anxiety and fear by showing alteration in all 
or some parameters, such as decreases in 
ambulation and exploration, immobilization or 
‘‘freezing’’, reduction in normal rearing and in 
grooming behavior, and increased micturition and 
defecation due to augmented autonomic activity 
(Novas et al., 1988). The oral administration of 
THME (150, 300 and 500 mg/kg) did not cause any 
significant change in the ambulation, rearing, 
preening, defecation and time of immobility 
compared to the control group over a 5-min period 
in mice. This study indicate that the THME did not 
exert sedative effects at any of the doses tested.  
The Sodium thiopental-induced sleeping 
time test in mice, is a classic method used to 
evaluate drugs with sedative-hypnotic properties. 
"Thiopental" is basically a hypnotic agent given at 
appropriate dose, induced hypnosis by potentiating 
GABA mediated postsynaptic inhibition through 
allosteric modification of GABAergic receptors. 
Substances which possess CNS depressant activity 
either decrease the time for onset of sleep or 
prolong the duration of sleep or both (Raihan et al., 
2011). In this test, the treatment with THME (150, 
300 and 500 mg/kg, p.o.) did not produce any 
significant change in the sleeping latency nor the 
sleeping time induced by sodium thiopental in mice. 
These results indicate that the THME did not exert 
hypnotic activity at any of the doses tested.  
 
CONCLUSIONS 
The present study demonstrated antipyretic activity 
of methanol extract of stems from Tabebuia 
hypoleuca administered orally in animal model, and 
suggest that this effect could be attributed to the 
inhibition of the enzyme COX-2. However, further 
investigations are required to identify the bioactive 
components responsible for the observed effect, and 
to determine the mechanism of action by which 
these compounds exert their antipyretic properties. 
Moreover, this study showed that THME no 
possesses sedative and hypnotic activities. This 
result therefore, demonstrated that antinociceptive 
activity of THME shown in previous studies has no 
relationship with CNS depression or sedation, 
eliminating the possibility of locomotor impairment 
in the antinociceptive activity of the extract. 
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